Takeda Launches New Subsidiary in Ecuador
Demonstrates Takeda's long-term commitment to the Latin American market
ZURICH, Switzerland, March 21, 2013 -- (Healthcare Sales & Marketing Network) --Takeda Pharmaceuticals International GmbH ("Takeda"), today announced further expansion of...
Biopharmaceuticals
Takeda Pharmaceutical, Takeda Ecuador
Biopharmaceuticals
Takeda Pharmaceutical, Takeda Ecuador
MEDICREA Receives FDA Pediatric Clearance for PASS(R) LP Systems
LYON, France--(Healthcare Sales & Marketing Network)--The MEDICREA group (FR0004178572-ALMED), listed on Alternext by NYSE Euronext Paris, a medical company specialized in the development of innovative surgical technologies for the treatment of spinal path...
Devices, Orthopaedic, Neurosurgery, FDA
MEDICREA, PASS LP, scoliosis, pedicle screw, spinal fusion
Devices, Orthopaedic, Neurosurgery, FDA
MEDICREA, PASS LP, scoliosis, pedicle screw, spinal fusion
Ethicon Receives 510(K) Clearance for ENSEAL(R) G2 Cordless
First of its Kind, Ready-to-Use Cordless Advanced Bipolar Energy Device Maintains Superior Sealing Benefits of ENSEAL® Tissue Sealers While Simplifying Set Up and Use
CINCINNATI--(Healthcare Sales & Marketing Network)--In an effort to continue impr...
Devices, Surgery, FDA
ETHICON, ENSEAL G2 Cordless, Tissue Sealer Device, bipolar tissue sealer
Devices, Surgery, FDA
ETHICON, ENSEAL G2 Cordless, Tissue Sealer Device, bipolar tissue sealer
Quantel Medical Receives FDA Clearance for new Vitra Multispot Laser System
CLERMONT-FERRAND, France, March 20, 2013 -- (Healthcare Sales & Marketing Network) -- Quantel Medical today announced the U.S. Food and Drug Administration (FDA) 510(k) market clearance of the Vitra Multispot laser. The product was developed by Quantel ...
Devices, Ophthalmology, FDA
Quantel Medical, Vitra Multispot, laser, diabetic eye disease
Devices, Ophthalmology, FDA
Quantel Medical, Vitra Multispot, laser, diabetic eye disease
Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
MONTREAL, March 20, 2013 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under which Valeant will acquire all of the outstand...
Biopharmaceuticals, Dermatology, Mergers & Acquisitions
Valeant Pharmaceuticals, Obagi Medical Products
Biopharmaceuticals, Dermatology, Mergers & Acquisitions
Valeant Pharmaceuticals, Obagi Medical Products
Smith and Nephew releases new Modular Rail System in collaboration with Dr. Dror Paley
LONDON, March 20, 2013 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the introduction of a new Modular Rail System (MRS) for external fixation and deformity correction. ...
Devices, Orthopaedic, Product Launch
Smith & Nephew, Modular Rail System, external fixation, TAYLOR SPATIAL FRAME
Devices, Orthopaedic, Product Launch
Smith & Nephew, Modular Rail System, external fixation, TAYLOR SPATIAL FRAME
Zimmer Launches a New Era in Knee Replacement with Persona(TM) The Personalized Knee System
Persona Knee Replacement Replicates the Anatomy and Biomechanics of the Knee for a Better Fit, More Natural Feel and More Normal Function
CHICAGO, March 20, 2013 -- (Healthcare Sales & Marketing Network) -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ...
Devices, Orthopaedic, Product Launch
Zimmer, Personalized Knee, Persona System, total knee
Devices, Orthopaedic, Product Launch
Zimmer, Personalized Knee, Persona System, total knee
Adamas Pharmaceuticals Presents New Traumatic Brain Injury Data From Its Nurelin(TM) Program At American Academy Of Neurology Conference
EMERYVILLE, Calif., March 20, 2013 -- (Healthcare Sales & Marketing Network) -- Adamas Pharmaceuticals, Inc. will present research results today from its NurelinTM (amantadine HCl extended release capsules) program demonstrating the benefit of amantadine i...
Biopharmaceuticals, Neurology
Adamas Pharmaceuticals, Nurelin, amantadine, traumatic brain injury
Biopharmaceuticals, Neurology
Adamas Pharmaceuticals, Nurelin, amantadine, traumatic brain injury
EOS imaging Receives FDA Clearance for 3D Imaging Software featuring Post-operative Hip Implant Assessment
EOS® 3D Orthopedic Imaging System with sterEOS® 1.5 to be Featured at AAOS 2013 Annual Meeting
CAMBRIDGE, Mass. & PARIS--(Healthcare Sales & Marketing Network)--EOS imaging (NYSE Euronext, FR0011191766 EOSI), the pioneer in 2D/3D orthopedic me...
Devices, Radiology, Orthopaedic, FDA
EOS imaging, sterEOS 3D imaging
Devices, Radiology, Orthopaedic, FDA
EOS imaging, sterEOS 3D imaging
AcuFocus Submits PMA to FDA for Approval of the KAMRA(TM) Inlay
First corneal inlay for presbyopia treatment submitted to FDA
IRVINE, Calif.--(Healthcare Sales & Marketing Network)--AcuFocus (www.AcuFocus.com) has submitted the final module of their premarket approval application (PMA) for the KAMRA corneal inlay t...
Devices, Ophthalmology, FDA
AcuFocus, KAMRA, corneal inlay, presbyopia
Devices, Ophthalmology, FDA
AcuFocus, KAMRA, corneal inlay, presbyopia
bioTheranostics Adds Chief Medical Officer and Vice President of Medical, Clinical and Regulatory Affairs
SAN DIEGO--(Healthcare Sales & Marketing Network)--bioTheranostics, Inc., a leading provider of molecular diagnostic solutions for metastatic cancer, today announced the appointment of Michael C. Dugan, M.D., as chief medical officer, and Catherine Schnabe...
Diagnostics, Oncology, Personnel
bioTheranostics, CancerTYPE ID
Diagnostics, Oncology, Personnel
bioTheranostics, CancerTYPE ID
Smith and Nephew launches natural-motion knee replacement at AAOS annual meeting
LONDON, March 19, 2013 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN NYSE:SNN), the global medical technology business, announces the showcasing of the JOURNEY II Bi-Cruciate Stabilized (BCS) knee replacement at this year's American...
Devices, Orthopaedic, Product Launch
Smith & Nephew, JOURNEY II, Bi-Cruciate Stabilized, knee replacement
Devices, Orthopaedic, Product Launch
Smith & Nephew, JOURNEY II, Bi-Cruciate Stabilized, knee replacement
Bioheart Expands Center of Excellence Program
SUNRISE, FL--(Healthcare Sales & Marketing Network) - Bioheart, Inc. ( OTCQB : BHRT ) announced today that it has expanded its Center of Excellence program to include a clinical site in Jamaica with the American Stem Cell and Anti-Aging Center. This site i...
Regenerative Medicine, Cardiology
Bioheart, LipiCell, stem cell
Regenerative Medicine, Cardiology
Bioheart, LipiCell, stem cell
BioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
FREDERICK, Md., March 19, 2013 -- (Healthcare Sales & Marketing Network) -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, technological solutions for chronic and post-operative wound care, announced today that it ...
Devices, Wound Care, Distribution
BioElectronics, Biomax Spa, RecoveryRx
Devices, Wound Care, Distribution
BioElectronics, Biomax Spa, RecoveryRx
SinuSys Corp. Expands Executive Team
PALO ALTO, Calif.--(Healthcare Sales & Marketing Network)--SinuSys Corporation, an innovative sinus health company, today announced recent additions to its management team as it expands its global commercialization activities for the SinuSys Dilation Syste...
Devices, Personnel
SinuSys, SinuSys Dilation System, Sinusitis
Devices, Personnel
SinuSys, SinuSys Dilation System, Sinusitis
Lantos Technologies Receives FDA Clearance for its 3D Ear Scanning System
The Lantos System is the First 3D Ear Scanning Technology to Attain Clearance as a 510(k) Medical Device
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Lantos Technologies, Inc. today announced that it has received clearance from the United S...
Devices, FDA
Lantos Technologies, 3D Ear Scanning System
Devices, FDA
Lantos Technologies, 3D Ear Scanning System
Cytomedix Announces Centers for Medicare and Medicaid Services (CMS) Issuance Of Reimbursement Coding for Autologous PRP in Chronic Non-Healing Wounds
Assignment of HCPCS Code Establishes Reimbursement Mechanism for Physicians and Other Healthcare Providers
GAITHERSBURG, MD--(Healthcare Sales & Marketing Network) - Cytomedix, Inc. ( OTCQX : CMXI ) (the "Company"), a regenerative therapies c...
Regenerative Medicine, Wound Care, Reimbursement
Cytomedix, AutoloGel, chronic non-healing wound
Regenerative Medicine, Wound Care, Reimbursement
Cytomedix, AutoloGel, chronic non-healing wound
Labrys Biologics Announces Key Executive Appointments
SAN FRANCISCO, March 18, 2013 -- (Healthcare Sales & Marketing Network) -- Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced key executive appointments to lead the development of RN-307, a Phase 2 ready anti-CGRP...
Biopharmaceuticals, Personnel
Labrys Biologics, RN-307, migraine
Biopharmaceuticals, Personnel
Labrys Biologics, RN-307, migraine
Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies
Creates One of World's Premier Aesthetic Laser and Light-Based Companies
Combines Best-of-Breed Technologies and Products
Strengthens Intellectual Property Portfolio with Additional Patents
Blends Complementary Cultures and Shared Commitment to In...
Devices, Dermatology, Mergers & Acquisitions
Cynosure, Palomar Medical Technologies
Devices, Dermatology, Mergers & Acquisitions
Cynosure, Palomar Medical Technologies
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
Dr. Allen is a hematologist/oncologist with a strong track record in drug development.
He joins Spectrum from AMAG Pharmaceuticals, Inc., where he had broad strategic and leadership roles as Chief Medical Officer, heading clinical development, medical a...
Biopharmaceuticals, Personnel
Spectrum Pharmaceuticals
Biopharmaceuticals, Personnel
Spectrum Pharmaceuticals

